Abstract:AIM: To study the effects of triptolide on in vitro cell proliferation and apoptosis in human lymphoma cell line Raji. METHODS: The experiment was conducted in the laboratory of the Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from April to November in 2005.①Human lymphoma cell line Raji was obtained from Shanghai Institute of Cell Biology, Chinese Academy of Sciences. Triptolide (C20H24O6, relative molecular weight 360.4, purity 99%) was purchased from Sigma Chemical Company and was initially dissolved in dimethyl sulfoxide. It was degermed by micropore filter membrane (0.22 μm), stored at equal dose at -20 ℃, and then thawed before use.②Raji cells were grown routinely in RPMI-1640 culture medium. The cells were passaged every 48 hours. The medium was changed half 24 hours before the experiment, and the cells grew at exponential phase of growth, whose viability was more than 98%, were used in the subsequent studies.③The effects of triptolide on the proliferation of Raji cells were detected by using MTT assay. The Raji cells (2×108 L-1) were incubated in a 96-well plate and 200 μL per well. There were 5 groups including experimental groups which the final concentration of each group were 12.5, 25, 50, 100 nmol/L and the negative control group which no drugs was added. The experiments were repeated for 5 times. And 20 μL MTT (5 g/L) was added to each well after the cells were cultured for 12,24,48,72 hours. Optical density (OD) was detected by a 96-well multiscanner autoreader at 490 nm wavelength. The cell proliferation inhibited rate (%)= 1-(OD of the experimental samples/OD of the control) ×100%.④The effects of triptolide on the apoptosis of Raji cells were detected by using Annexin Ⅴ/PI double-labeled cytometry. The Raji cells (2×108 L-1) were incubated in a 6-well plate, and the cells were grouped as above. Then cells were harvested after cultured for 24 and 48 hours, respectively, with the density of cells were adjusted to 2×108 L-1. And 195 μL cell suspension was obtained which FITC labeled Annexin Ⅴ was added and incubated at room temperature. Afterwards the cells were washed and 5 μL PI was added. The cell apoptosis analysis was performed on flow cytometry. RESULTS: ①The effects of triptolide on the proliferation of the Raji cells: Different concentrations of triptolide could inhibit the growth of Raji cells in a dose- and time-dependent manner. Compared with the negative control group, the inhibition rate of cell proliferation was increased significantly in triptolide-treated groups (t=18.314-77.366, P < 0.01), and the 24-hour 50% growth inhibitory concentration was 43.06 nmol/L.②The effects of triptolide on the apoptosis of Raji cells: The cell apoptosis rate was increased accordingly as the treatment concentration increased and the culture time extended. The effects were dose- and time-dependent, and the apoptosis was increased obviously in comparison with the negative control group (t=-23.657 to -37.895, P < 0.01=. CONCLUSION: Triptolide has a significant inhibiting effect on the proliferation in human lymphoma cell line Raji, and the inhibition is dose- and time- dependent. Moreover, triptolide also induce the apoptosis of Raji cells in a dose-and time-dependent manner. In short, triptolide can inhibit the cell proliferation through inducing the apoptosis of Raji cells, and it may be hopeful to be a new drug to treat lymphoma.

Triptolide Inhibits Lipopolysaccharide-Induced Proliferation, Induces Apoptosis And Causes Cell Cycle Arrest Of Human Mesangial Cells In Vitro

Modulatory Effect of Triptolide on Differentiation of Human Th17 Cells

[Study of Triptolide-Induced Apoptosis in MUTZ-1 Cells and Its Allied Mechanism].

Triptolide protects podocytes via autophagy in immunoglobulin A nephropathy.

Triptolide Down-regulates Bcr-abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

[Effect of Triptolide on Human Oral Cancer Cell Proliferation and PTEN Gene Mrna Expression in Oral Cancer].

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways

Effect of Triptolide on the Proliferation and Apoptosis of Human Epidermal Squamous Cell Carcinoma Cell Line A431 in Vitro

Triptolide Induced Cell Death Through Apoptosis and Autophagy in Murine Leukemia WEHI‐3 Cells in Vitro and Promoting Immune Responses in WEHI‐3 Generated Leukemia Mice in Vivo

Involvement of Mitochondrial Pathway in Triptolide-Induced Cytotoxicity in Human Normal Liver L-02 Cells

Triptolide Induces S Phase Arrest Via the Inhibition of Cyclin E and CDC25A and Triggers Apoptosis Via Caspase- and Mitochondrial-Dependent Signaling Pathways in A375.S2 Human Melanoma Cells

Triptolide Down-Regulates Tumor Necrosis Factor-Α and Interferon-Γ-induced Overexpression of Monocyte Chemoattractant Protein-1 in Human Proximal Tubular Epithelial Cells

Triptolide Alters Histone H3K9 and H3K27 Methylation State and Induces G0/G1 Arrest and Caspase-Dependent Apoptosis in Multiple Myeloma in Vitro.

Triptolide (PG-490) Induces Apoptosis of Dendritic Cells Through Sequential P38 MAP Kinase Phosphorylation and Caspase 3 Activation.

Triptolide Suppresses CD80 and CD86 Expressions and IL-12 Production in THP-1 Cells1

Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway

Triptolide Inhibits Cell Growth and Induces G0-G1 Arrest by Regulating P21wap1/Cip1 and P27 Kip1 in Human Multiple Myeloma Rpmi-8226 Cells

The Effect of Triptolide on Proliferation of Fibroblasts ABSTRACT

Triptolide Induces Cell Apoptosis by Targeting H3K4me3 and Downstream Effector Proteins in KM3 Multiple Myeloma Cells

TRIPTOLIDE INHIBITS MCP-10VERPRODUCTION IN HUMAN PROXIMAL TUBULAR CELLS INDUCED BYIFNγ AND TNFα COSTIMULATION

Effects of triptolide on the proliferation and apoptosis of human lymphoma cells